European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, F. Morschhauser, Paul Fields et al.|Haematologica|2016Cited by 48
Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific AntibodiesGiulia Losi, Alberto Mussetti, Marta Peña et al.|Blood|2024Cited by 0